论文部分内容阅读
专注于医药保健和作物科学业务材料科技最晚将于2016年上市拜耳和材料科技都将受益于此剥离计划员工人数在未来几年内将保持稳定拜耳集团计划在未来完全专注于生命科学业务——医药保健和作物科学,而材料科技将被剥离,并进入股票市场。拜耳集团正通过此举将自己定位为一家在人类、动物和植保领域处于世界级领先地位的公司。近日拜耳监事会一致通过了管理委员会方案。“我们的目标是创建两家全球顶级的企业:生命科学领域的世界级创新公司——拜耳,以及聚合物领域
Focused on Healthcare and CropScience Business Materials Technology to be listed in 2016 at the latest Bayer MaterialScience will benefit from this divestment program Staff numbers to stabilize in coming years Bayer Group plans to fully focus on life sciences business in the future - Medical care and crop science, while materials technology will be stripped and enter the stock market. The Bayer Group is positioning itself as a world-class company in the human, animal and plant protection sectors. Recently Bayer Supervisory Board unanimously adopted the management committee program. ”Our goal is to create two of the world’s top companies: world-class innovation company in the life sciences Bayer, as well as the polymer field